| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9756 |
| Human Intestinal Absorption | HIA+ | 0.9602 |
| Caco-2 Permeability | Caco2+ | 0.8019 |
| P-glycoprotein Substrate | Non-substrate | 0.7441 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9721 |
| Non-inhibitor | 0.9533 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9169 |
| Distribution |
| Subcellular localization | Plasma membrane | 0.6002 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8259 |
| CYP450 2D6 Substrate | Non-substrate | 0.8900 |
| CYP450 3A4 Substrate | Non-substrate | 0.7149 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.6478 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9108 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9444 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9432 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9737 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9459 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8595 |
| Non-inhibitor | 0.9162 |
| AMES Toxicity | Non AMES toxic | 0.9868 |
| Carcinogens | Carcinogens | 0.5000 |
| Fish Toxicity | High FHMT | 0.9204 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8900 |
| Honey Bee Toxicity | High HBT | 0.6812 |
| Biodegradation | Ready biodegradable | 0.9701 |
| Acute Oral Toxicity | III | 0.7711 |
| Carcinogenicity (Three-class) | Non-required | 0.7008 |